共 189 条
[1]
Babjuk M(2022)European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ) Eur Urol 81 75-94
[2]
Burger M(2016)Mutation drivers of immunological responses to cancer Cancer Immunol Res 4 789-798
[3]
Capoun O(2008)How to build and interpret a nomogram for cancer prognosis J Clin Oncol 26 1364-1370
[4]
Cohen D(2016)Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use J Clin Oncol 107 4331-510
[5]
Compérat EM(2022)Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery Int J Surg 20 496-4349
[6]
Dominguez Escrig JL(2022)Comprehensive analysis of anoikis-related long non-coding RNA immune infiltration in patients with bladder cancer and immunotherapy Front Immunol 17 218-641
[7]
Gontero P(2019)Molecular docking: shifting paradigms in drug discovery Int J Mol Sci 7 4331-639
[8]
Liedberg F(2016)Regulating rho GTPases and their regulators Nat Rev Mol Cell Biol 216 627-569
[9]
Masson-Lecomte A(2020)RAC3 promotes proliferation, migration and invasion via PYCR1/JAK/STAT signaling in bladder cancer Front Mol Biosci 44 628-556.e25
[10]
Mostafid AH(2017)Rac3 regulates breast cancer invasion and metastasis by controlling adhesion and matrix degradation J Cell Biol 12 560-2852